Alexander Mustea

1.9k total citations
55 papers, 938 citations indexed

About

Alexander Mustea is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alexander Mustea has authored 55 papers receiving a total of 938 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Obstetrics and Gynecology, 16 papers in Reproductive Medicine and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alexander Mustea's work include Endometrial and Cervical Cancer Treatments (20 papers), Ovarian cancer diagnosis and treatment (12 papers) and Plasma Applications and Diagnostics (9 papers). Alexander Mustea is often cited by papers focused on Endometrial and Cervical Cancer Treatments (20 papers), Ovarian cancer diagnosis and treatment (12 papers) and Plasma Applications and Diagnostics (9 papers). Alexander Mustea collaborates with scholars based in Germany, Austria and United States. Alexander Mustea's co-authors include Jalid Sehouli, Matthias B. Stope, Johann Pratschke, Udo Baron, Christoph Loddenkemper, Hans‐Dieter Volk, Ulrich Hoffmüller, Rodiça Lenkei, Anne Marie Asemissen and Carmen Scheibenbogen and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Alexander Mustea

50 papers receiving 916 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander Mustea Germany 14 293 243 239 198 197 55 938
Daisy M. D. S. Sie‐Go Netherlands 19 396 1.4× 227 0.9× 246 1.0× 257 1.3× 97 0.5× 33 1.0k
Astrid Petersen Denmark 17 342 1.2× 156 0.6× 96 0.4× 152 0.8× 186 0.9× 52 984
William P. Irvin United States 17 210 0.7× 225 0.9× 180 0.8× 227 1.1× 158 0.8× 26 821
Jitze M. Duk Netherlands 13 388 1.3× 266 1.1× 167 0.7× 194 1.0× 139 0.7× 15 794
Nader Husseinzadeh United States 18 299 1.0× 292 1.2× 278 1.2× 256 1.3× 270 1.4× 48 1.2k
Anisa Kanbour United States 19 240 0.8× 234 1.0× 210 0.9× 251 1.3× 73 0.4× 44 942
Nak Woo Lee South Korea 20 311 1.1× 221 0.9× 74 0.3× 238 1.2× 388 2.0× 71 1.1k
David Millan United Kingdom 18 273 0.9× 266 1.1× 76 0.3× 184 0.9× 368 1.9× 41 996
Zeina Ghorab Canada 18 291 1.0× 162 0.7× 46 0.2× 196 1.0× 145 0.7× 62 892
Yoko Harima Japan 17 267 0.9× 212 0.9× 42 0.2× 178 0.9× 359 1.8× 42 1.0k

Countries citing papers authored by Alexander Mustea

Since Specialization
Citations

This map shows the geographic impact of Alexander Mustea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Mustea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Mustea more than expected).

Fields of papers citing papers by Alexander Mustea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Mustea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Mustea. The network helps show where Alexander Mustea may publish in the future.

Co-authorship network of co-authors of Alexander Mustea

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Mustea. A scholar is included among the top collaborators of Alexander Mustea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Mustea. Alexander Mustea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mao, Xiaodan, Qibin Wu, Pingping Su, et al.. (2025). Antagonism of estrogen-related receptor-α inhibits mitochondrial oxidative phosphorylation and reduces M2 macrophage infiltration in endometrial cancer. Journal for ImmunoTherapy of Cancer. 13(9). e012521–e012521.
2.
Mao, Xiaodan, Lixiang Huang, Xianhua Liu, et al.. (2025). High glucose levels promote glycolysis and cholesterol synthesis via ERRα and suppress the autophagy–lysosomal pathway in endometrial cancer. Cell Death and Disease. 16(1). 182–182. 2 indexed citations
3.
Egger, Eva K., Tobias Hilbert, Damian J. Ralser, et al.. (2024). Intraoperative Fluid Balance and Perioperative Complications in Ovarian Cancer Surgery. Annals of Surgical Oncology. 31(13). 8944–8951.
4.
Alkatout, İbrahim, Rudy Leon De Wilde, Jörg Herrmann, et al.. (2024). Adhesion Prevention in Gynecologic Surgery: Guidance and Clinical Experience. Journal of Clinical Medicine. 13(24). 7517–7517.
5.
Mustea, Alexander, Damian J. Ralser, Eva K. Egger, et al.. (2024). Determination of endometrial cancer molecular subtypes using a whole exome-sequencing based single-method approach. Journal of Cancer Research and Clinical Oncology. 150(7). 367–367. 2 indexed citations
6.
Condic, Mateja, Christian Staerk, Thomas Zillinger, et al.. (2024). Immune Profiling of Vulvar Squamous Cell Cancer Discovers a Macrophage-rich Subtype Associated with Poor Prognosis. Cancer Research Communications. 4(3). 861–875. 1 indexed citations
7.
Weimer, Jörg, Matthias B. Stope, Edgar Dahl, et al.. (2023). Fluorescence in situ hybridization test for detection of endometrial carcinoma cells by non‐invasive vaginal swab. Journal of Cellular and Molecular Medicine. 27(3). 379–391. 4 indexed citations
8.
Sander, Caroline, Martin Weiß, Eva K. Egger, et al.. (2023). Pleiotropic Devitalization of Renal Cancer Cells by Non-Invasive Physical Plasma: Characterization of Molecular and Cellular Efficacy. Cancers. 15(2). 481–481. 5 indexed citations
9.
Mustea, Alexander, Damian J. Ralser, Eva K. Egger, et al.. (2023). Determination of the Cancer Genome Atlas (TCGA) Endometrial Cancer Molecular Subtypes Using the Variant Interpretation and Clinical Decision Support Software MH Guide. Cancers. 15(7). 2053–2053. 6 indexed citations
10.
Egger, Eva K., Mateja Condic, Damian J. Ralser, et al.. (2023). The Role of P16, P53, KI-67 and PD-L1 Immunostaining in Primary Vaginal Cancer. Cancers. 15(4). 1046–1046. 1 indexed citations
11.
Condic, Mateja, Eva K. Egger, Niklas Klümper, et al.. (2023). TROP-2 is widely expressed in vulvar squamous cell carcinoma and represents a potential new therapeutic target. Journal of Cancer Research and Clinical Oncology. 149(11). 8235–8241. 10 indexed citations
12.
Condic, Mateja, et al.. (2023). Intraoperative Utilization of Indocyanine Green (ICG) Dye for the Assessment of Ovarian Perfusion—Case Report and Review of the Literature. Journal of Clinical Medicine. 12(18). 5923–5923. 3 indexed citations
13.
Condic, Mateja, Thore Thiesler, Kirsten Kübler, et al.. (2022). N6-methyladenosine (m6A) RNA modification is dysregulated in endometrial cancer. Geburtshilfe und Frauenheilkunde. 82(10). e57–e57. 1 indexed citations
14.
Condic, Mateja, Thore Thiesler, Niklas Klümper, et al.. (2022). N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma. BMC Cancer. 22(1). 943–943. 2 indexed citations
15.
Ralser, Damian J., Mateja Condic, Niklas Klümper, et al.. (2022). Comprehensive immunohistochemical analysis of N6-methyladenosine (m6A) writers, erasers, and readers in endometrial cancer. Journal of Cancer Research and Clinical Oncology. 149(6). 2417–2424. 11 indexed citations
16.
Bien-Möller, Sandra, Sascha Marx, Sander Bekeschus, et al.. (2022). Devitalization of Glioblastoma Cancer Cells by Non-invasive Physical Plasma: Modulation of Proliferative Signalling Cascades. Anticancer Research. 43(1). 7–18. 10 indexed citations
17.
Woelber, Linn, Katharina Prieske, Christine zu Eulenburg, et al.. (2021). Adjuvant radiotherapy and local recurrence in vulvar cancer – a subset analysis of the AGO-CaRE-1 study. Gynecologic Oncology. 164(1). 68–75. 17 indexed citations
18.
Mahner, Sven�, J Jueckstock, Felix Hilpert, et al.. (2015). Adjuvant Therapy in Lymph Node–Positive Vulvar Cancer: The AGO-CaRE-1 Study. JNCI Journal of the National Cancer Institute. 107(3). 128 indexed citations
19.
Mustea, Alexander, Dominique Koensgen, Antje Belau, et al.. (2013). Adjuvant sequential chemoradiation therapy in high-risk endometrial cancer: results of a prospective, multicenter phase-II study of the NOGGO (North-Eastern German Society of Gynaecological Oncology). Cancer Chemotherapy and Pharmacology. 72(5). 975–983. 13 indexed citations
20.
Kriegshäuser, Gernot, Dan Cacsire Castillo‐Tong, Reinhard Horvat, et al.. (2009). KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay. BMC Cancer. 9(1). 111–111. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026